UNSPSC 85742311: Revision of synthetic substitute in fallopian tube, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of synthetic substitute in fallopian tube, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0UW83JZ

UNSPSC 85742311 Revision of synthetic substitute in fallopian tube, percutaneous approach (Commodity) does not align with the recent state and local opportunities tagged under this code. The source shows no procurement activity for gynecological implant procedures or related medical devices; the tagged opportunities instead cover independent medical evaluation services, pharmacy benefit management, occupational health surveillance, surgical care networks, specialty medical staffing, and youth detention health services—none of which involve fallopian tube procedures or synthetic substitutes. The code classification appears misapplied across the opportunities in the dataset.

The opportunities posted under this code reflect general occupational and administrative health services procurement by state departments, county governments, and public health systems. The City of Phoenix Retirement Office (RFP RTMRFP26001, due October 16, 2026) is requesting independent medical evaluation and disability review services with a five-year contract ceiling of $750,000; the Washington State Department of Transportation's ferries division (RFP RFP20260825, due October 9, 2026) is seeking occupational medical surveillance across 14 locations in Washington State; and the County of Santa Clara Health System (RFSQHHSFY270052, due October 7, 2026) is establishing a qualified vendor pool for temporary health professional staffing in ancillary clinical specialties. Collier County (RFP 25-8414, due April 9, 2026) issued an RFP for pharmacy benefit management covering approximately 7,200 covered members with historical annual pharmacy spending near $8.7 million. Activity appears concentrated in Arizona, Washington State, California, and Florida, with no clear geographic concentration. The mismatch between the code's nominal scope and actual recent opportunities suggests this code is not an active procurement channel for the medical device or procedure category its name describes.